Loading...
Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
Despite advances in cytotoxic chemotherapy and targeted therapies, 5-year survival rates remain low for patients with advanced breast cancer at diagnosis. This highlights the limited effectiveness of current treatment options. An improved understanding of cellular functions associated with the devel...
Saved in:
| Published in: | Onco Targets Ther |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4676614/ https://ncbi.nlm.nih.gov/pubmed/26675495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S88037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|